Amgen discloses that it has experienced a cybersecurity incident in which sensitive data was stolen. Multiple outlets report that the company informs it has suffered a breach and has taken steps in response, including assessing the scope of the incident and the nature of the information affected. According to the reports, Amgen states that patient information was involved, including health-related data. The company’s disclosures indicate that the stolen information is limited to certain categories of records and does not involve operational disruption at a level described in the coverage. The reports also note that Amgen is working to investigate the matter, determine whether any additional systems or data sets are impacted, and evaluate potential risks to affected individuals.
While the sources differ mainly in the way they describe the incident and the category of data affected, all agree on the core points: Amgen confirms a data breach, characterizes it as a cybersecurity incident, and says patient health information was stolen. The disclosures are presented as part of the company’s efforts to inform stakeholders about the incident.
